论文部分内容阅读
AIM: To evaluate pre-treatment factors associatedwith sustained virological response (SVR) in patientswith hepatitis C virus (HCV) genotype 3 treated withpeginterferon and ribavirin (RBV).METHODS: We retrospectively analyzed treatmentnaive, mono-infected